SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001513160-14-000079
Filing Date
2014-12-12
Accepted
2014-12-12 16:40:44
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 OXIS INTERNATIONAL QUARTERLY REPORT oxis10q063013.htm 10-Q 563932
2 CERTIFICATION SECTION 302 ex311.htm EX-31.1 12209
3 CERTIFICATION SECTION 302 ex312.htm EX-31.2 12203
4 CERTIFICATION SECTION 906 ex321.htm EX-32.1 5943
5 CERTIFICATION SECTION 906 ex322.htm EX-32.2 5941
  Complete submission text file 0001513160-14-000079.txt   2405094

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT oxis-20130630.xml EX-101.INS 230541
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oxis-20130630.xsd EX-101.SCH 20137
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT oxis-20130630_cal.xml EX-101.CAL 35070
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT oxis-20130630_def.xml EX-101.DEF 43522
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oxis-20130630_lab.xml EX-101.LAB 156781
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oxis-20130630_pre.xml EX-101.PRE 116612
Mailing Address 468 N. CAMDEN DR. 2ND FLOOR BEVERLY HILLS CA 90210
Business Address 468 N. CAMDEN DR. 2ND FLOOR BEVERLY HILLS CA 90210 (310) 551-4020
OXIS INTERNATIONAL INC (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-08092 | Film No.: 141284106
SIC: 2834 Pharmaceutical Preparations